Philadelphia FIGHT (FIGHT) was founded as the Community-Based Research Initiative on AIDS as a partnership of individuals living with HIV/AIDS and clinicians who joined together to improve the lives of people living with the disease by testing potential treatments for HIV/AIDS and its complications. Today, clinicians at FIGHT continue to be involved in a number of studies.
What is a clinical trial?
A clinical trial is a controlled experiment in which people take medication for a specified time to determine its effectiveness and safety. Information gathered from clinical trials help create future treatments. Clinical trials are currently the most effective way to help people who have exhausted all proven therapies and to develop new and better treatments for people living with HIV/AIDS.
Who can enroll in a trial?
Each clinical trial has specific requirements; anyone meeting those requirements may be eligible to enroll in a trial. FIGHT clinical trials are free and participation is voluntary. Before participating in a study, patients go through a consenting process, which explains all the risks and benefits of that particular study. Participants may withdraw from clinical trials at any time without affecting access to their health care.
Click the link to view ongoing trials conducted at Philadelphia FIGHT Community Health Centers.
If you are interested in participating in clinical trials, please contact the research staff of Philadelphia FIGHT at 215-525-8695.
Thinking of conducting research at FIGHT?
If you would like to collaborate with a FIGHT investigator or conduct a research trial at FIGHT, please fill out the Philadelphia FIGHT Community Health Centers Research Conduct Proposal Form and return it to firstname.lastname@example.org. If you would like to recruit for an ongoing research trial from the FIGHT client-base, please forward your IRB approved advertisements to Linden along with a brief description of your research.
What’s new in FIGHT Research?
The Philadelphia FIGHT Research Department is honored to remain a part of the BEAT-HIV Delaney Collaboratory. The Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) is a consortium of more than 30 top HIV researchers from leading academic research institutions working with government, nonprofit organizations, and industry partners to test combinations of several novel immunotherapies under new preclinical research and clinical trials. For more information, please visit http://beat-hiv.org/